BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2006
The purpose of this study is to determine if BHT-3009 decreases inflammation (measured by gadolinium enhancing MRI lesions) in the brains of people with relapsing remitting multiple sclerosis.
Epistemonikos ID: da3c2e456e2c67671c83c3b9dc60749d19757ab7
First added on: Mar 31, 2022